Status:
COMPLETED
The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema
Lead Sponsor:
Neon Hospital
Collaborating Sponsors:
Ondokuz Mayıs University
Conditions:
Diabetic Macular Edema
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study evaluates the effects of subconjunctivally injected bevacizumab in patients with diffuse diabetic macular edema.
Detailed Description
At baseline, the macular thicknesses of both eyes of the patients with persistant diabetic macular edema were measured by optical coherence tomography. After 3.75mg bevacizumab was injected into subco...
Eligibility Criteria
Inclusion
- Having diffuse diabetic macular edema persisted at least 1 month
- No intravitreal injection in last 3 months.
- No retinal laser photocoagulation in last 6 months
- Not have any other macular disease causing macular edema
Exclusion
- Having ischemic macula
- Intravitreal injection in last 3 months.
- Retinal laser photocoagulation in last 6 months
- Have any other macular disease causing macular edema
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02796183
Start Date
January 1 2015
End Date
May 1 2016
Last Update
June 10 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.